Torsten Mummenbrauer

Torsten is CEO of ExeVir Bio. He brings nearly 25 years of experience in biotech and pharma to the role. In prior roles, Torsten served as CEO of Velvio GmbH, Senior Vice President Business Development of Hookipa Pharma, Senior Director Business Development of Morphosys and Vice President Business Development of GSK, leading the transaction team of GSK vaccines. Torsten is reviewer of the German biotech seed fund program GoBio since almost 10 years and holds a PhD in Tumor Virology and Immunology from the University Hospital Hamburg. Beyond his pharma and biotech engagement Torsten loves biking, skiing and windsurfing.